Notable Labs Company Overview
Notable Labs
About Notable Labs
Notable Labs (NASDAQ:NTBL) is a clinical-stage biotech company on the NASDAQ exchange. They develop "predictive precision medicines" for cancer patients. Their core technology, the Predictive Precision Medicines Platform (PPMP), uses bio-simulation to predict a patient's response to treatment before it's administered. This aims to identify ideal candidates and accelerate drug development. Notable Labs focuses on unmet medical needs in cancer treatment, with Volasertib, a drug for acute myeloid leukemia, as their lead program. Their stock price is currently $0.99.
What is Notable Labs known for?
Snapshot
2014
Year founded
16
Employees
Foster City, United States
Head office
Loading Map...
Operations
All Locations
United States
Produtos e/ou serviços de Notable Labs
- Predictive Precision Medicines Platform (PPMP): This is their core technology, a platform that uses bio-simulation to predict patient response to cancer treatment.
- Predictive Precision Medicines Development: They leverage PPMP to develop new, targeted cancer drugs.
- Clinical Trial Design & Patient Selection: Notable Labs might design clinical trials for their drugs and use PPMP to select ideal participants.
- Partnerships for Drug Development & Commercialization: They could potentially partner with other companies to develop and sell their predicted precision medicines.
- Licensing of PPMP Technology: There's a possibility they might license their PPMP technology to other institutions in the future.
- Cancer Research & Collaboration: Notable Labs likely collaborates with research institutions to further develop cancer treatments.
equipe executiva do Notable Labs
- Mr. Scott Alan McPherson CFE, CPA, CVAChief Financial Officer
- Dr. Joseph P. Wagner Ph.D.Chief Scientific Officer
- Ms. Kaile ZaggerInterim CEO & Chief Restructuring Officer
- Dr. Glenn C. Michelson M.D.Chief Medical Officer